nivolumab,repotrectinib,luspatercept,ipilimumab,lisocabtagene maraleucel
bms
['nivo', 'lung', 'mds', 'reblozyl', ' ipi ', 'repotrectinib', 'bms', '$bmy']
bms $bmy #asco23 key data mds: reblozyl (actriib activin receptor type iib) sll: isocabtagene maraleucel (cd19 car-t) lung: repotrectinib (tkr alk, ros1, and ntrk1-3) lung: nivo (pd1) + ipi (ctla4) (link to subst***ack in bio) 
Bi-Weekly Biotech Updates: Public & Private Market Updates, Company Building, Financing, Exit Strategies, and Emerging Science Trends | Current: Biotech VC